122 related articles for article (PubMed ID: 37231994)
1. Loss of MD1 Promotes Inflammatory and Apoptotic Atrial Remodelling in Diabetic Cardiomyopathy by Activating the TLR4/NF-κB Signalling Pathway.
Shi T; Wang G; Peng J; Chen M
Pharmacology; 2023; 108(4):311-320. PubMed ID: 37231994
[TBL] [Abstract][Full Text] [Related]
2. MD1 Deficiency Promotes Inflammatory Atrial Remodelling Induced by High-Fat Diets.
Shuai W; Kong B; Fu H; Shen C; Jiang X; Huang H
Can J Cardiol; 2019 Feb; 35(2):208-216. PubMed ID: 30760428
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of MD1 ameliorates pathological myocardial remodeling in diabetic cardiomyopathy by TLR4/STAT3 signaling pathway.
Shen C; Yang S; Wu N; Jian W; Du T; Chu H; Du W
Mol Cell Endocrinol; 2024 Jun; 592():112315. PubMed ID: 38878954
[TBL] [Abstract][Full Text] [Related]
4. Loss of MD1 exacerbates myocardial ischemia/reperfusion injury and susceptibility to ventricular arrhythmia.
Jiang X; Kong B; Shuai W; Shen C; Yang F; Fu H; Huang H
Eur J Pharmacol; 2019 Feb; 844():79-86. PubMed ID: 30458167
[TBL] [Abstract][Full Text] [Related]
5. The Akt pathway mediates the protective effects of myeloid differentiation protein 1 in pathological cardiac remodelling.
Peng J; Zeng G; Zhong P; Wang G; Lei C; Tian G; Chen J; Wu J; Shen C
ESC Heart Fail; 2021 Aug; 8(4):3214-3222. PubMed ID: 34041859
[TBL] [Abstract][Full Text] [Related]
6. Synergistic cardioptotection by tilianin and syringin in diabetic cardiomyopathy involves interaction of TLR4/NF-κB/NLRP3 and PGC1a/SIRT3 pathways.
Yao J; Li Y; Jin Y; Chen Y; Tian L; He W
Int Immunopharmacol; 2021 Jul; 96():107728. PubMed ID: 33971494
[TBL] [Abstract][Full Text] [Related]
7. Blockage of DCLK1 in cardiomyocytes suppresses myocardial inflammation and alleviates diabetic cardiomyopathy in streptozotocin-induced diabetic mice.
Ji L; Yang X; Jin Y; Li L; Yang B; Zhu W; Xu M; Wang Y; Wu G; Luo W; Lee K; Liang G
Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166900. PubMed ID: 37778481
[TBL] [Abstract][Full Text] [Related]
8. Loss of myeloid differentiation protein 1 promotes atrial fibrillation in heart failure with preserved ejection fraction.
Shuai W; Kong B; Yang H; Fu H; Huang H
ESC Heart Fail; 2020 Apr; 7(2):626-638. PubMed ID: 31994333
[TBL] [Abstract][Full Text] [Related]
9. MiR-20a-5p overexpression prevented diabetic cardiomyopathy via inhibition of cardiomyocyte apoptosis, hypertrophy, fibrosis and JNK/NF-κB signalling pathway.
Liu X; Guo B; Zhang W; Ma B; Li Y
J Biochem; 2021 Oct; 170(3):349-362. PubMed ID: 33837411
[TBL] [Abstract][Full Text] [Related]
10. MD1 Depletion Predisposes to Ventricular Arrhythmias in the Setting of Myocardial Infarction.
Fu H; Shuai W; Kong B; Jiang X; Huang H
Heart Lung Circ; 2021 Jun; 30(6):869-881. PubMed ID: 33257269
[TBL] [Abstract][Full Text] [Related]
11. [Experimental study on effect and mechanism of Danzhi Jiangtang Capsules on diabetic myocardial injury].
Shi H; Wang L; Fang ZH; Ni YQ; Shen AL; Liu PP; Wang X; Huang JL
Zhongguo Zhong Yao Za Zhi; 2019 Dec; 44(23):5159-5165. PubMed ID: 32237353
[TBL] [Abstract][Full Text] [Related]
12. TLR4 knockout ameliorates streptozotocin-induced osteoporosis in a mouse model of diabetes.
Cao Y; Han X; Wang Z; Liu Y; Wang Y; Zhang R; Ye J; Zou L; Dai W
Biochem Biophys Res Commun; 2021 Mar; 546():185-191. PubMed ID: 33601314
[TBL] [Abstract][Full Text] [Related]
13. Loss of MD1 increases vulnerability to ventricular arrhythmia in diet-induced obesity mice via enhanced activation of the TLR4/MyD88/CaMKII signaling pathway.
Shuai W; Kong B; Fu H; Shen C; Huang H
Nutr Metab Cardiovasc Dis; 2019 Sep; 29(9):991-998. PubMed ID: 31353205
[TBL] [Abstract][Full Text] [Related]
14. Akap1 deficiency exacerbates diabetic cardiomyopathy in mice by NDUFS1-mediated mitochondrial dysfunction and apoptosis.
Qi B; He L; Zhao Y; Zhang L; He Y; Li J; Li C; Zhang B; Huang Q; Xing J; Li F; Li Y; Ji L
Diabetologia; 2020 May; 63(5):1072-1087. PubMed ID: 32072193
[TBL] [Abstract][Full Text] [Related]
15. Compound c17 alleviates inflammatory cardiomyopathy in streptozotocin-induced diabetic mice by targeting MyD88.
Zhang Q; Zhu W; Lou S; Bao H; Zhou Y; Cai Z; Ye J; Cui Y; Wang M; Jin L; Liang G; Luo W; Wang Y
Int Immunopharmacol; 2023 Nov; 124(Pt A):110863. PubMed ID: 37703787
[TBL] [Abstract][Full Text] [Related]
16. CAPE-pNO
Fan L; Xiao Q; Zhang L; Wang X; Huang Q; Li S; Zhao X; Li Z
Biomed Pharmacother; 2018 Dec; 108():1640-1650. PubMed ID: 30372866
[TBL] [Abstract][Full Text] [Related]
17. Probucol prevents atrial remodeling by inhibiting oxidative stress and TNF-α/NF-κB/TGF-β signal transduction pathway in alloxan-induced diabetic rabbits.
Fu H; Li G; Liu C; Li J; Wang X; Cheng L; Liu T
J Cardiovasc Electrophysiol; 2015 Feb; 26(2):211-22. PubMed ID: 25199622
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory Serine Proteases Play a Critical Role in the Early Pathogenesis of Diabetic Cardiomyopathy.
Kolpakov MA; Sikder K; Sarkar A; Chaki S; Shukla SK; Guo X; Qi Z; Barbery C; Sabri A; Rafiq K
Cell Physiol Biochem; 2019; 53(6):982-998. PubMed ID: 31829530
[TBL] [Abstract][Full Text] [Related]
19. Blockage of MyD88 in cardiomyocytes alleviates cardiac inflammation and cardiomyopathy in experimental diabetic mice.
Luo W; Wu G; Chen X; Zhang Q; Zou C; Wang J; Liu J; Chattipakorn N; Wang Y; Liang G
Biochem Pharmacol; 2022 Dec; 206():115292. PubMed ID: 36241098
[TBL] [Abstract][Full Text] [Related]
20. An Aza resveratrol-chalcone derivative 6b protects mice against diabetic cardiomyopathy by alleviating inflammation and oxidative stress.
You S; Qian J; Sun C; Zhang H; Ye S; Chen T; Xu Z; Wang J; Huang W; Liang G
J Cell Mol Med; 2018 Mar; 22(3):1931-1943. PubMed ID: 29327811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
